
Transthoracic echocardiography can help clinicians predict short-term mortality outcomes for patients with acute pulmonary embolism (PE), according to a study published online August 26 in the Journal of the American Heart Association.
The findings could lead to better care strategies for patients at risk of cardiovascular disease, wrote a team led by Dr. Behnood Bikdeli of Columbia University Medical Center/NewYork-Presbyterian Hospital in New York City.
"Acute pulmonary embolism is a serious thromboembolic condition accounting for thousands of hospitalizations and associated with high short-term mortality rates," the group wrote. "Some studies suggest that transthoracic echocardiography could help in the early risk stratification of patients with acute PE."
Although transthoracic echocardiography is often used to assess patients with acute PE within 72 hours of diagnosis -- and its utilization has increased in recent years -- it has been unclear exactly how effective it is, according to Bikdeli and colleagues.
"[Research] results have been inconsistent and the use of transthoracic echocardiography in real life and its prognostic value have not been consistently studied," they wrote.
To remedy this, the researchers used data from RIETE (Registro Informatizado Enfermedad TromboEmbolica), a registry coordinated by Spanish researchers that includes 35,395 patients who experienced acute pulmonary embolism between 2001 and 2017. They evaluated the association between three variables (right atrial enlargement, right ventricular hypokinesis, and right heart thrombi) and 30-day PE-related mortality. The group adjusted data for demographics, PE severity, and other comorbidities.
Among the study cohort, 42.8% of patients underwent transthoracic echocardiography. Overall, younger, female patients with a history of heart disease, heart failure, atrial fibrillation, tachycardia, and hypotension had a higher incidence of transthoracic echocardiography use. Of the study participants, 5.3% died within the first 30 days after presenting with PE; of these, 29.7% died of PE.
| Findings on transthoracic echo that predict PE mortality | |
| Finding | Odds ratio for 30-day PE-related mortality |
| Right heart thrombi | 8.51 |
| Right atrial enlargement | 6.69 |
| Right ventricular hypokinesis | 5.59 |
"In our study ... early transthoracic echocardiography was performed in over one-third of patients, and the proportion increased over time," the group wrote. "History of prior cardiovascular disease ... and clinical markers of PE severity were among the main predictors of early transthoracic echocardiography."
Bikdeli and colleagues hope their findings will prompt further research.
"Future studies should identify the optimal management strategies for high-risk subgroups identified by early echocardiography," they concluded.



















![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)
